REMS Training Requirements: Certification and Ongoing Duties

REMS training requirements apply when a drug’s Risk Evaluation and Mitigation Strategy includes Elements to Assure Safe Use (ETASU) that restrict who can prescribe, dispense, or administer it. If the drug you plan to prescribe or dispense falls in that category, you must complete the manufacturer’s drug-specific training, enroll in the program, and hold an active certification before a pharmacy will fill the prescription. The FDA has approved more than 300 REMS programs since 2008, and only a subset carry these training obligations.1Food and Drug Administration. Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard

When REMS Training Actually Applies to You

REMS training is not a blanket obligation on all providers. Many REMS programs consist only of a Medication Guide and require no special provider training at all.2Food and Drug Administration. Risk Evaluation and Mitigation Strategies – Possible Components of a REMS The programs that impose real obligations are those with ETASU, because those are the ones that restrict how the drug can be prescribed, dispensed, or administered.

Certification is always drug-specific. Completing one REMS program does not satisfy the requirements for a different REMS drug, so a provider prescribing three medications with ETASU will hold three separate certifications. Prescribers who need certification typically include any licensed professional authorized to write prescriptions for the drug: physicians, nurse practitioners, and physician assistants.3Food and Drug Administration. Background Materials for REMS Standardization and Evaluation Public Meeting – REMS Tools – Section: Enrollment and Certification of Healthcare Providers Dispensing entities also need separate certification in many programs, including retail pharmacies, specialty pharmacies, and settings like infusion centers.4Food and Drug Administration. What’s in a REMS? – Section: Required Activities or Clinical Interventions Certified pharmacies are often required to train their staff annually and keep records of that training.

By statute, any REMS training or certification requirement must be available through a widely accessible method such as an online course or a mail-based program at reasonable cost, so distance or location cannot lock you out.5Office of the Law Revision Counsel. 21 US Code 355-1 – Risk Evaluation and Mitigation Strategies

What the Training Covers

Each REMS training module is built around the specific serious risk the FDA wants to manage, so content varies from drug to drug. Most modules address a common set of topics.

Training starts with the drug’s identified serious risks: which patients should not receive it and what clinical warning signs to watch for. Prescribers learn the patient selection criteria — who is an appropriate candidate and who faces unacceptable risk. Most programs also cover the required monitoring schedule, which may include specific laboratory tests at set intervals, clinical assessments, or mandatory follow-up visits, and some drugs require you to confirm test results before every refill.4Food and Drug Administration. What’s in a REMS? – Section: Required Activities or Clinical Interventions

Programs that use a patient registry will walk you through enrollment, what data you must report, and the timeline for submissions. Training also covers documentation duties. Many REMS programs require you to provide FDA-approved patient education materials, such as the Medication Guide, at specific points during treatment and to document that patients received and understood them. Some programs require signed patient acknowledgment forms confirming counseling on the drug’s risks.

How to Complete REMS Certification

The drug manufacturer or program sponsor builds and maintains the training infrastructure. The starting point for any provider is the REMS@FDA database, which lists every approved REMS and links to each program’s materials and manufacturer portal.4Food and Drug Administration. What’s in a REMS? – Section: Required Activities or Clinical Interventions From there, the typical sequence looks like this:

  • Create an account on the program’s portal using your National Provider Identifier (NPI), DEA number (if applicable), and demographic information.
  • Work through the training modules. These are usually self-paced online courses covering the drug’s risks, monitoring requirements, and safety protocols.
  • Pass the knowledge assessment. Some programs require a passing score on a test; others require you to attest that you understand and agree to the program’s conditions.
  • Sign and submit the prescriber or dispenser enrollment form. As part of enrollment, you agree to carry out specific safe-use activities, such as counseling patients and completing required monitoring.4Food and Drug Administration. What’s in a REMS? – Section: Required Activities or Clinical Interventions
  • Receive your certification confirmation or enrollment ID, which pharmacies can verify before dispensing.

Keep your certification records accessible. Pharmacies dispensing REMS drugs must verify that the prescriber is certified, that the patient is enrolled where required, and that any lab tests or safe-use conditions have been met before releasing the medication.4Food and Drug Administration. What’s in a REMS? – Section: Required Activities or Clinical Interventions If your certification has lapsed or cannot be verified, the pharmacy will not fill the prescription.

Recertification and Ongoing Duties

Initial certification is not the finish line. Many REMS programs require periodic recertification, and the timeline varies by drug. Some operate on a 12-month cycle. Others require recertification whenever the REMS materials are updated or modified. The TIRF REMS, for instance, required all previously enrolled prescribers to complete entirely new training, pass a new knowledge assessment, and re-enroll when the program underwent significant changes.6Food and Drug Administration. Questions and Answers FDA Approves Class Risk Evaluation and Mitigation Strategy (REMS) for Transmucosal Immediate Release Fentanyl

Your day-to-day REMS obligations continue for as long as you prescribe the drug. Patient monitoring, registry reporting, and counseling requirements do not stop once you finish the training. Failing to report when a patient discontinues treatment, or neglecting to submit required lab results, can put your enrollment at risk. Each program specifies what ongoing activities you must perform, and the program administrator tracks compliance.

What Happens If You Skip It

The most immediate consequence is practical: the prescription does not get filled. Certified pharmacies verify prescriber status before dispensing, and an uncertified prescriber’s order will be rejected at the pharmacy.4Food and Drug Administration. What’s in a REMS? – Section: Required Activities or Clinical Interventions Compliance is built into the distribution chain rather than left to individual discretion.

Non-compliance also carries professional risk. Failing to follow REMS safety protocols can affect your prescribing privileges and increase your exposure to malpractice liability. If a patient suffers a serious adverse event the REMS was designed to prevent, the fact that you did not follow the required steps becomes powerful evidence against you. REMS documentation creates a clear, auditable standard of care, and deviating from it gives plaintiffs’ attorneys a straightforward argument that you fell below it. For dispensing pharmacies, the stakes track the same logic: a pharmacy that dispenses a REMS drug without verifying prescriber certification or safe-use conditions risks its own REMS status and regulatory standing.

REMS Training Is Not MATE Act Training

Providers sometimes confuse REMS certification with the training required under the Mainstreaming Addiction Treatment (MATE) Act, which took effect in June 2023. They are separate obligations with different triggers.

The MATE Act requires all DEA-registered practitioners (except those who exclusively treat animals) to complete at least eight hours of training on treating and managing patients with opioid or other substance use disorders. This training is a prerequisite for obtaining or renewing a DEA registration, whether or not the practitioner ever prescribes opioids.7Drug Enforcement Administration. MATE Act FAQ

REMS training applies only when you prescribe or dispense a specific drug with ETASU requirements. It is tied to the individual medication, not to your DEA registration. Completing your MATE Act training does not certify you under any REMS, and completing a REMS does not satisfy MATE Act hours. Some educational providers bundle both, offering curricula that count for MATE Act hours while covering opioid-related REMS content, but the two requirements remain independent.

Continuing Education Credit

Some REMS training qualifies for Continuing Medical Education (CME) or Continuing Education (CE) credit, but this depends on how the training is structured and who delivers it. The Accreditation Council for Continuing Medical Education has supported accredited continuing education as a component of FDA REMS programs since 2009, provided the education meets independence and quality standards.8Accreditation Council for Continuing Medical Education. FDA REMS

In practice, many manufacturer-sponsored REMS modules do not carry CME credit on their own, while third-party accredited providers have developed curricula that align with REMS requirements and offer credit. Opioid REMS-compliant curricula, for example, are available through accredited providers offering AMA PRA Category 1 Credits. If credit toward license renewal matters to you, check whether the specific REMS offers an accredited training pathway before defaulting to the manufacturer’s standard module. Both routes satisfy the REMS requirement; only the accredited version counts toward your renewal hours.

Finding Your Specific Program’s Requirements

Because every REMS is drug-specific, the details that matter most — exactly what training you need, what monitoring you must perform, and how often to recertify — live in the individual program materials, not in any single set of universal rules. The FDA’s REMS@FDA database at accessdata.fda.gov/scripts/cder/rems is the definitive lookup for any approved REMS.9Food and Drug Administration. Risk Evaluation and Mitigation Strategies (REMS) Each entry links to the full REMS document and the manufacturer’s program site, where you can register and begin certification. If you are unsure whether a medication you plan to prescribe carries an active REMS, that database will tell you within a few clicks.